Trading with Minimalist

[Minimalist]

Mind Medicine (MindMed) Inc. (NEO:MMED) (OTCQB:MMEDF) (FRA:BGHM)

(17:36 | 5th June 2020 | Live Price - 0.3592)

During the 70s, a small pharma company Eli Lilly (at the time) produced an anti-depressant drug creating the first major treatment for depression. This drug went on to become a household name - Prozac.

Its considered an “essential medicine” by the World Health Organization

With the current lock downs in place and stay-at-home orders are running all types of mental health and addictions are going to skyrocket. During isolation consumption of addictive substances can increase by 19 times than normal.

This lock down has seen a massive scale of unemployment which will enable not only a great financial depression, but also a great depression of mental health and addiction.

In 2018, the American FDA gave the green light to pharma companies to test psychedelics.

Mind Medicine (MindMed) Inc. is a next-gen neuro-pharmaceutical company that discovers, develops and deploys treatments derived from psychedelics to improve health, promote wellness and alleviate suffering.

MindMed Is Developing a Treatment for Addiction “drug addiction is a disease of the brain” – Dr. Nora Volkow, MD, Director, National Institute on Drug Abuse

In April, MindMed announced the signing of a multi-year collaboration a world-leading psychedelics pharmacology and clinical research group at University Hospital Basel. MindMed gains exclusive worldwide rights to data, compounds and patent rights.

 

Im a big OTC trader due to the purchasing power.

Trading at these levels this is a great opportunity to make profits from a potential breakout. OTCs is the way to go.